We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 123

JCAHO revisions to medical staff standards will impact role of medical executive committees

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • February 8 2010

The Joint Commission has posted proposed changes to its Medical Staff Standard that will likely change how Medical Staffs relate to their Medical Executive Committees

HIPAA compliance deadline is rapidly approaching

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • September 5 2013

Earlier this year, the Department of Health and Human Services (HHS) issued the final privacy and security regulations under the Health Insurance

Physician Payment Sunshine Act: proposed rule leaves big questions unanswered

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • January 20 2012

The Centers for Medicare and Medicaid Services (“CMS”) has released a proposed rule to implement the “Physician Payment Sunshine Act” (the “Sunshine Act”), enacted as part of the Patient Protection and Affordable Care Act of 2010 (the “ACA”

Pfizer subs hit with $34.7 million criminal kickback penalties for off-label promotions

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • May 30 2007

The Pharmacia & Upjohn subsidiaries of Pfizer agreed to a combined settlement of $34.7 million with the United States on April 2, 2007

Unconventional medical care and FMLA coverage

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • March 28 2011

We have a diverse workforce

Accessing mental health records in a physical disability case

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • November 22 2010

One of our employees recently claimed that he is entitled to a reasonable accommodation of his physical disability (a serious back problem

Actavis case analysis: Supreme Court says certain patent infringement settlements could violate antitrust laws

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • June 27 2013

On June 17, 2013, the Supreme Court issued its much-anticipated ruling in Federal Trade Commission v. Actavis, Inc. et al. (No. 12-416), holding that

U.S. Supreme Court declines to resolve circuit split regarding administrative and outside sales exemptions under the FLSA

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • March 4 2011

On February 28, 2011, the U.S. Supreme Court announced its decision to deny certiorari in the closely watched cases of Novartis Pharmaceuticals Corp. v. Lopes, No. 10-460, and Kuzinski v. Schering Corp., No. 10-459

New OIG advisory opinions

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • February 4 2009

On November 25, 2008, the Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) issued Advisory Opinion No. 08-21, in which the OIG reiterated its position regarding gainsharing arrangements, this time in the context of cardiac catheterization procedures

The Supreme Court addresses pay-for-delay in FTC v. Actavis

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • June 17 2013

FTC v. Actavis, Inc., No. 12-416: Respondent Solvay Pharmaceuticals obtained a patent for its approved brand-name drug, and subsequently